What Is Longevity Medicine? 9 Treatments That Help You Age Slower in India

Ageing is not a single event. It is a continuous biological process — measurable, modifiable, and increasingly understood at the molecular level.

For most of human history, medicine concerned itself with treating disease after it appeared. Longevity medicine operates from a fundamentally different premise: that the biological processes driving ageing can be identified, measured, and meaningfully slowed before disease emerges — and that the quality and capacity of life in middle age and beyond is not fixed by genetics but shaped decisively by how well those processes are managed.

In India, this field is arriving at precisely the right moment. A rapidly ageing population, rising rates of metabolic disease, and a growing urban professional class that is both health-literate and time-pressured has created the conditions for longevity medicine to move from the margins of wellness culture into mainstream preventive healthcare.

At L&B Clinics, we are at the forefront of this shift in Delhi — integrating the latest evidence in longevity science with individualised clinical protocols that address the specific physiological realities of ageing in the Indian context: nutritional patterns, environmental stressors, genetic predispositions, and lifestyle factors that are distinct from the Western populations in which much longevity research has historically been conducted.

This is what longevity medicine actually is — and the nine treatments that the evidence most strongly supports.

What Longevity Medicine Actually Means

Longevity medicine — also referred to as precision longevity, healthspan medicine, or geroscience-informed care — is the clinical application of research into the biological hallmarks of ageing to slow their progression, reverse their effects where possible, and extend not just lifespan but healthspan: the proportion of life spent in full physical and cognitive function.

The scientific foundation of longevity medicine was significantly advanced by López-Otín et al. (2013) in their landmark Cell paper identifying the hallmarks of ageing — a framework of twelve core biological processes that drive the ageing phenotype: genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, disabled macroautophagy, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, altered intercellular communication, chronic inflammation, and dysbiosis.

Each of these hallmarks is measurable. Each is influenced by clinical interventions. And each, when adequately addressed, contributes to a measurable reduction in biological age — the age at which your body is functioning, as distinct from your chronological age.

This is the core distinction longevity medicine makes: chronological age is fixed. Biological age is not.

NAD+ IV Therapy — Restoring the Cellular Energy Currency

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in every cell of the body and is central to mitochondrial energy production, DNA repair, and the activation of sirtuins — a family of proteins with direct anti-ageing and metabolic regulatory functions.

NAD+ levels decline by approximately 50 percent between the ages of 40 and 60, and this decline is now recognised as a primary driver of mitochondrial dysfunction — one of the hallmarks of ageing (Verdin, 2015). Reduced NAD+ means reduced cellular energy production, impaired DNA repair capacity, and diminished sirtuin activity — all of which accelerate the ageing process at the cellular level.

IV NAD+ therapy delivers the coenzyme directly into the bloodstream, bypassing the significant conversion inefficiency of oral NAD+ precursors. Research published in Nature Metabolism demonstrated that IV NAD+ administration produces rapid and substantial increases in circulating NAD+ levels, with downstream improvements in mitochondrial function, cognitive performance, and physical energy (Yoshino et al., 2021).

At L&B Clinics, NAD+ IV therapy is administered over a structured protocol, typically 2 to 4 hours per session, with dosing determined by individual assessment. It is among the most significant interventions in the longevity medicine toolkit — directly addressing one of the most well-characterised mechanisms of biological ageing.

Glutathione IV Therapy — Fighting the Oxidative Damage That Ages You

Oxidative stress — the accumulation of free radical damage to DNA, proteins, and lipid membranes — is among the most extensively studied contributors to cellular ageing. Glutathione is the body's primary intracellular antioxidant and the central regulator of oxidative balance in every tissue.

Glutathione levels decline significantly with age — by up to 30 to 40 percent between young adulthood and the sixth decade — reducing the cell's capacity to neutralise free radical damage, maintain mitochondrial integrity, and support the immune surveillance functions that become increasingly important as ageing progresses (Pizzorno, 2014).

In the Indian context, environmental oxidative load is particularly high. Urban air pollution — Delhi consistently records some of the highest PM2.5 concentrations globally — generates continuous systemic free radical burden that depletes glutathione reserves at an accelerated rate relative to less polluted environments.

IV glutathione at L&B Clinics delivers the antioxidant at 100% bioavailability — bypassing the digestive breakdown that renders oral glutathione largely ineffective for systemic tissue delivery. Regular IV glutathione as part of a longevity protocol supports liver detoxification, skin health, immune function, and the broader antioxidant environment in which other longevity interventions operate most effectively (Weschawalit et al., 2017).

Myers' Cocktail IV Therapy — The Nutritional Foundation of Cellular Function

Nutrient deficiency is one of the most underappreciated accelerants of biological ageing — and in India, it is extraordinarily prevalent. The Indian dietary landscape, despite its diversity, carries well-documented deficiencies in magnesium, vitamin B12, vitamin D, zinc, and vitamin C across broad population segments (Bharati et al., 2018).

These are not trivial gaps. Magnesium is a cofactor in over 300 enzymatic reactions, including ATP synthesis, DNA repair, and protein synthesis. B12 is essential for neurological integrity and red blood cell production. Vitamin C is required for collagen synthesis and antioxidant defence. Zinc drives immune competence and cellular proliferation. Deficiencies in any of these nutrients directly accelerate the hallmarks of ageing — genomic instability, mitochondrial dysfunction, and cellular senescence.

The Myers' Cocktail — a precisely formulated intravenous combination of magnesium, calcium, B vitamins, and high-dose vitamin C — delivers the complete nutritional foundation that cellular function requires, at plasma concentrations that oral supplementation cannot reliably achieve (Gaby, 2002).

As the base of the L&B Clinics longevity IV protocol, the Myers' Cocktail addresses nutritional deficiency comprehensively — creating the biochemical environment in which more targeted longevity interventions can function optimally.

High-Dose Vitamin C IV Therapy — Collagen, Immunity, and Epigenetic Repair

Vitamin C's role in longevity medicine extends considerably beyond its antioxidant function.

Vitamin C is a cofactor for the ten-eleven translocation (TET) enzymes — the molecular machinery responsible for DNA demethylation, a critical component of epigenetic regulation. Epigenetic alterations — one of the primary hallmarks of ageing — involve the progressive dysregulation of gene expression patterns, accelerating the functional decline of tissues and organs. TET enzyme activity, supported by adequate vitamin C, is essential for maintaining appropriate epigenetic programming and resisting age-related gene expression drift (Cimmino et al., 2018).

At the plasma concentrations achievable only through IV delivery — up to 70 times higher than oral supplementation can produce — vitamin C meaningfully supports TET-mediated epigenetic maintenance, collagen synthesis, immune surveillance, and antioxidant recycling simultaneously (Levine et al., 2011).

For Indian patients navigating high UV environments, elevated pollution exposure, and often chronically insufficient dietary vitamin C intake, high-dose IV vitamin C is not simply a wellness supplement — it is a mechanistically grounded longevity intervention.

Hormone Optimisation — Addressing the Endocrine Drivers of Ageing

The age-related decline in key anabolic and regulatory hormones — testosterone, oestrogen, progesterone, DHEA, thyroid hormones, and growth hormone — is one of the most clinically consequential dimensions of biological ageing. These hormones govern muscle mass retention, bone density, cognitive function, metabolic rate, cardiovascular health, and emotional resilience.

In India, the perimenopausal and andropausal transitions — the periods of hormonal decline in women and men respectively — are still significantly underdiagnosed and undertreated. Many patients present with symptoms of hormonal ageing — fatigue, cognitive fog, reduced muscle strength, mood instability, poor sleep, weight gain — that are attributed to "normal ageing" rather than recognised as a modifiable endocrine process.

Longevity medicine approaches hormonal decline through comprehensive assessment — detailed serum hormone panels interpreted in the context of symptoms and functional status — followed by evidence-based optimisation strategies tailored to the individual. At L&B Clinics, hormone evaluation is integrated into the longevity assessment, with treatment recommendations guided by clinical evidence and the patient's specific health goals (Stachenfeld, 2008).

Metabolic and Mitochondrial Optimisation — Addressing the Energy Engine of Ageing

Mitochondrial dysfunction — the progressive deterioration of the cellular organelles responsible for producing ATP, the body's energy currency — is recognised as a central hallmark of ageing and a driver of virtually every age-related disease (López-Otín et al., 2013).

Clinically, mitochondrial decline manifests as the fatigue, reduced physical capacity, slower recovery, and metabolic inflexibility that most people associate with "getting older." In India's context, this is compounded by widespread insulin resistance — driven by dietary patterns high in refined carbohydrates, physical inactivity, and the specific metabolic susceptibility of South Asian genetics — which further impairs mitochondrial function.

Longevity medicine addresses mitochondrial health through a combination of NAD+ restoration, targeted supplementation with coenzyme Q10 and alpha-lipoic acid, structured dietary strategies — including time-restricted eating protocols with an emerging evidence base for mitochondrial protection — and exercise prescription optimised for mitochondrial biogenesis (Martínez-Reyes and Chandel, 2020).

At L&B Clinics, mitochondrial health is assessed and addressed as a central pillar of every longevity protocol — because without adequate cellular energy production, no other longevity intervention operates at full efficacy.

Comprehensive Biomarker Testing — Measuring Biological Age, Not Just Cholesterol

You cannot optimise what you cannot measure.

Conventional annual health check-ups in India — fasting glucose, lipid panel, CBC, thyroid function — were designed to diagnose established disease, not to identify the biological processes driving ageing a decade before they produce a diagnosable condition.

Longevity medicine operates from a fundamentally different testing philosophy. Advanced biomarker panels used at L&B Clinics in longevity assessments include inflammatory markers — high-sensitivity CRP, interleukin-6, and homocysteine, which predict cardiovascular and neurological ageing risk years before clinical disease; oxidative stress markers; hormonal panels far more comprehensive than standard checks; micronutrient status panels identifying the specific deficiencies driving biological ageing in the individual; and, increasingly, epigenetic biological age clocks — tests that measure the methylation patterns of DNA to generate an actual biological age estimate (Horvath, 2013).

This data transforms longevity medicine from a generalised wellness programme into a precision intervention — identifying exactly where in the hallmarks of ageing each individual is most vulnerable and directing therapeutic resources accordingly.

Personalised Nutrition and IV Micronutrient Protocols — Correcting the Indian Deficiency Landscape

India's nutritional epidemiology is distinctive and clinically significant for longevity medicine.

The combination of widespread vegetarianism — with associated B12, zinc, and complete protein deficiencies — phytate-rich staple foods that impair mineral absorption, historically low vitamin D levels due to indoor work culture despite high-UV environments, and the metabolic consequences of a rapidly westernised dietary pattern creates a nutritional landscape that accelerates several hallmarks of ageing simultaneously (Bharati et al., 2018).

Personalised nutrition in the L&B Clinics longevity programme begins with comprehensive micronutrient assessment, followed by a dietary protocol designed around the individual's specific deficiency profile, food preferences, and metabolic characteristics. IV micronutrient therapy — sessions designed to rapidly correct identified deficiencies at therapeutic concentrations — bridges the gap between where the patient's nutritional status is and where it needs to be for optimal biological function.

The principle is straightforward: you cannot build collagen without vitamin C, repair DNA without zinc and B12, produce cellular energy without magnesium and B vitamins, or regulate inflammation without adequate omega-3 fatty acids. Longevity medicine ensures these substrates are present at the levels the biology actually requires — not simply at levels sufficient to avoid clinical deficiency disease.

Mind-Body and Cortisol Management — The Longevity Factor Nobody Talks About Enough

Chronic psychological stress is not simply an emotional experience. It is a longevity-relevant biological phenomenon.

Elevated cortisol — the primary stress hormone — accelerates telomere shortening, suppresses immune function, promotes systemic inflammation, impairs insulin sensitivity, and disrupts sleep architecture, all of which directly accelerate the hallmarks of ageing (Epel et al., 2004). Research from the Proceedings of the National Academy of Sciences demonstrated that chronic psychological stress produces measurable telomere shortening equivalent to ten additional years of biological ageing in some populations.

For urban Indian professionals — navigating demanding careers, family obligations, traffic, pollution, and the ambient anxiety of a rapidly changing social and economic environment — cortisol burden is high, chronic, and largely normalised.

Longevity medicine takes cortisol management seriously as a clinical intervention — not simply as a recommendation to "reduce stress." At L&B Clinics, this involves objective assessment of adrenal function and cortisol rhythm, IV magnesium and B-complex therapy to support adrenal resilience and neurotransmitter balance, and structured protocol guidance around sleep, recovery, and evidence-based stress reduction practices that have demonstrated cortisol-lowering and longevity-promoting effects in clinical research (Boyle, Lawton and Dye, 2017).

Longevity Medicine in India in 2026 — Why Now Is the Right Time

The convergence of advancing longevity science, increasing biomarker accessibility, growing awareness among Indian health consumers, and the availability of clinically grounded longevity programmes at institutions like L&B Clinics means that meaningful biological age management is no longer a distant aspiration.

It is available now, in Delhi, to anyone willing to approach their health with the same rigour and investment they bring to their career or financial planning.

The question longevity medicine asks is not "how do I avoid dying?" It is "how do I ensure that the years I have are lived at full capacity — cognitively sharp, physically vital, emotionally resilient, and free from the preventable diseases that compress healthspan?"

That question has answers. They are evidence-backed, clinically deliverable, and available at L&B Clinics.

References

Bharati, S., Pal, M., Bhattacharya, B.N. and Bharati, P. (2018) 'Prevalence of and factors associated with micronutrient deficiencies in Indian women', Journal of Health, Population and Nutrition, 37(1), p. 4. https://doi.org/10.1186/s41043-018-0135-7

Boyle, N.B., Lawton, C. and Dye, L. (2017) 'The effects of magnesium supplementation on subjective anxiety and stress — a systematic review', Nutrients, 9(5), p. 429. https://doi.org/10.3390/nu9050429

Cimmino, L., Dolgalev, I., Wang, Y., Yoshimi, A. and Aifantis, I. (2018) 'Restoration of TET2 function blocks aberrant self-renewal and leukemia progression', Cell, 170(6), pp. 1079–1095. https://doi.org/10.1016/j.cell.2017.07.032

Epel, E.S., Blackburn, E.H., Lin, J., Dhabhar, F.S. and Morrow, J.D. (2004) 'Accelerated telomere shortening in response to life stress', Proceedings of the National Academy of Sciences, 101(49), pp. 17312–17315. https://doi.org/10.1073/pnas.0407162101

Gaby, A.R. (2002) 'Intravenous nutrient therapy: the "Myers' cocktail"', Alternative Medicine Review, 7(5), pp. 389–403.

Horvath, S. (2013) 'DNA methylation age of human tissues and cell types', Genome Biology, 14(10), p. R115. https://doi.org/10.1186/gb-2013-14-10-r115

Levine, M., Padayatty, S.J. and Espey, M.G. (2011) 'Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries', Advances in Nutrition, 2(2), pp. 78–88. https://doi.org/10.3945/an.110.000109

López-Otín, C., Blasco, M.A., Partridge, L., Serrano, M. and Kroemer, G. (2013) 'The hallmarks of aging', Cell, 153(6), pp. 1194–1217. https://doi.org/10.1016/j.cell.2013.05.039

Martínez-Reyes, I. and Chandel, N.S. (2020) 'Mitochondrial TCA cycle metabolites control physiology and disease', Nature Communications, 11(1), p. 102. https://doi.org/10.1038/s41467-019-13668-3

Pizzorno, J. (2014) 'Glutathione!', Integrative Medicine: A Clinician's Journal, 13(1), pp. 8–12.

Stachenfeld, N.S. (2008) 'Sex hormone effects on body fluid regulation', Exercise and Sport Sciences Reviews, 36(3), pp. 152–159. https://doi.org/10.1097/JES.0b013e31817be928

Verdin, E. (2015) 'NAD+ in aging, metabolism, and neurodegeneration', Science, 350(6265), pp. 1208–1213. https://doi.org/10.1126/science.aac4854

Weschawalit, S., Thongthip, S., Phutrakool, P. and Asawanonda, P. (2017) 'Glutathione and its antiaging and antimelanogenic effects', Clinical, Cosmetic and Investigational Dermatology, 10, pp. 147–153. https://doi.org/10.2147/CCID.S128339

Yoshino, M., Yoshino, J., Kayser, B.D., Patti, G.J. and Imai, S. (2021) 'Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women', Science, 372(6547), pp. 1224–1229. https://doi.org/10.1126/science.abe9985